The goal of the National Institute of Drug Abuse (NIDA) Clinical Trials Network/Addiction Technology Transfer Center (ATTC) webinar series is to help scholars and clinicians in the addiction field stay abreast of cutting-edge science.
In this session, Keith Humphreys, PhD (Stanford University) will explore the landscape of mutual help groups and the diverse mutual help groups that are available to patients. The clinical and cost effectiveness of group and 12-step programs will also be reviewed. Lastly, the clinical and policy implications of mutual help groups for promoting recovery from addiction will be discussed.
- Identify at least two essential and two optional features of addiction-focused mutual help groups.
- Recall at least two research studies that examined the effectiveness and health care cost-offset of 12-step mutual help groups.
- Specify at least two clinical and two policy strategies for increased rates of recovery in mutual help groups.
1.5 CME or CE credits available: AMA PRA Category 1 CreditsTM; PSY (APA); RN (CA BRN); LMFT, LCSW, LPCC, LEP (CAMFT); RADT I/II, CADC-CAS, CADC I/II, CADC-CS, LAADC (CCAPP); CATC (ACCBC/CAADE); CAODC (CADTP)
Sponsored by the Northwest and Pacific Southwest Addiction Technology Transfer Centers (ATTCs) and the Western States Node of the NIDA Clinical Trials Network.